SC
ELV icon

Searle & Co’s Elevance Health ELV Stock Holding History

Searle & Co’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$969K Buy
2,506
+150
+6% +$55.6K 0.22% 86
2026
Q1 		$690K Sell
2,356
-250
-10% -$82.2K 0.17% 108
2025
Q4 		$914K Hold
2,606
– – 0.24% 85
2025
Q3 		$842K Hold
2,606
– – 0.22% 92
2025
Q2 		$1.01M Hold
2,606
– – 0.29% 75
2025
Q1 		$1.13M Sell
2,606
-220
-8% -$88.3K 0.32% 72
2024
Q4 		$1.04M Hold
2,826
– – 0.3% 73
2024
Q3 		$1.47M Hold
2,826
– – 0.37% 60
2024
Q2 		$1.53M Buy
2,826
+49
+2% +$25.9K 0.36% 63
2024
Q1 		$1.44M Sell
2,777
-13
-0.5% -$6.46K 0.37% 63
2023
Q4 		$1.32M Sell
2,790
-75
-3% -$34.7K 0.36% 65
2023
Q3 		$1.25M Hold
2,865
– – 0.42% 59
2023
Q2 		$1.35M Buy
2,865
+75
+3% +$34.6K 0.42% 60
2023
Q1 		$1.31M Sell
2,790
-500
-15% -$238K 0.43% 57
2022
Q4 		$1.69M Hold
3,290
– – 0.58% 50
2022
Q3 		$1.49M Hold
3,290
– – 0.57% 51
2022
Q2 		$1.59M Hold
3,290
– – 0.63% 49
2022
Q1 		$1.62M Hold
3,290
– – 0.6% 53
2021
Q4 		$1.52M Hold
3,290
– – 0.55% 57
2021
Q3 		$1.23M Hold
3,290
– – 0.5% 61
2021
Q2 		$1.26M Hold
3,290
– – 0.51% 60
2021
Q1 		$1.18M Hold
3,290
– – 0.53% 59
2020
Q4 		$1.06M Hold
3,290
– – 0.51% 58
2020
Q3 		$884K Sell
3,290
-50
-1% -$13.5K 0.48% 59
2020
Q2 		$878K Hold
3,340
– – 0.51% 56
2020
Q1 		$758K Buy
3,340
+500
+18% +$136K 0.54% 56
2019
Q4 		$858K Buy
+2,840
New +$782K 0.47% 62

Other funds holding ELV

AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
FI
Focused Investors Los Angeles, California $2.96B AUM 15.6% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Searle & Co's ELV Position: Q2 2026 in Review

Searle & Co increased its Elevance Health (ELV) stake by 6.4% in Q2 2026, buying an estimated $55.6K and bringing the position to 2,506 shares worth $969K. The position accounts for 0.22% of the portfolio, ranked #86.

Searle & Co first reported a position in ELV in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.69M in Q4 2022. 637 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Searle & Co held 2,506 shares of Elevance Health worth $969K as of Q2 2026.
  • Searle & Co bought 150 Elevance Health shares in Q2 2026, an estimated $55.6K.
  • Elevance Health made up 0.22% of Searle & Co's portfolio in Q2 2026, its #86 holding.
  • Searle & Co first reported a position in Elevance Health in Q4 2019 and has held it in 27 quarters since.
  • Searle & Co's Elevance Health position peaked at $1.69M in Q4 2022.
  • 637 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Searle & Co's 13F filing for Q2 2026, filed 27 Jul 2026.